Search Results 791-800 of 19761 for Receptor

1. A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects with Early Stage Triple Negative Breast Cancer - Mayo Clinic

   Estrogen Receptor (ER)-, Progesterone Receptor (PR)-, and Human Epidermal Growth Factor Receptor (HER)2-negative (triple-negative) cancer of the breast.

2. Publications - Matthew M. Colontonio, M.D. - Mayo Clinic

   New opioid receptor modulators and agonists. Best Pract Res Clin Anaesthesiol. 2018 Jun; 32 (2):125-136 Epub 2018 July 02. View PubMed. PST-20566941. Home ...

3. Mayo Clinic researchers study new class of drugs to treat multiple myeloma

   "CAR-T (chimeric antigen receptor-T cell therapy) cell therapy, which uses a patient's own modified immune cells to kill cancerous tumors, is arguably one ...

4. Cancer to COVID-19: Experimental treatment pivots in record time - Mayo Clinic News Network

   B., a Mayo Clinic cancer researcher, studies a type of cancer therapy called chimeric antigen receptor-T cell therapy, or CAR-T cell therapy. It was hailed ...

5. Trial of 225Ac-DOTATATE (RYZ101) Alone and with Pembrolizumab in Subjects with ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs (TRACY-1) - Mayo Clinic

   ... receptor positive (ER+), human epidermal growth factor receptor 2 (HER2)-negative, unresectable, locally advanced and unresectable or metastatic breast cancer.

6. Pseudobulbar affect - Diagnosis and treatment - Mayo Clinic

   This combination medicine works to block some receptors and activate others in the brain. Receptors are proteins on the surface of cells that receive messages ...

7. Publications - Robert M. Cuddihy, M.D. - Mayo Clinic

   Multivariate analysis of HLA loci in conjunction with a thyrotropin receptor codon 52 polymorphism in conferring risk of Graves' disease. Thyroid. 1996 Aug; 6(4): ...

8. Publications - Ruth Lupu, Ph.D. - Mayo Clinic

   Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer. Aging (Albany NY). 2020 Dec 10; 12(24):24671 ...

9. Isobel A. Scarisbrick, Ph.D. - Mayo Clinic Faculty Profiles

   These new roles for activated receptors include stem cell expansion ... In addition to new druggable receptor targets, Dr. Scarisbrick's lab team ...

10. Publications - Cornelius A. Thiels, D.O., M.B.A. - Mayo Clinic

    Diagnostic performance of somatostatin receptor positron emission tomography in preoperative evaluation of pancreatic neuroendocrine tumor lymph node metastases ...